Impact of early growth delay on subsequent fetal growth and functional development: a study on diabetic pregnancy

E J Mulder1, G H Visser

  • 1Department of Obstetrics and Gynaecology, Utrecht University Hospital, Netherlands.

Early Human Development
|December 1, 1992
PubMed

Insights

Early growth delay in type-1 diabetic pregnancies impacts fetal behavioral development, not birth weight. This suggests early embryonic disorders affect later functional development, while catch-up growth occurs later in pregnancy.

Area of Science:

  • Reproductive Medicine
  • Developmental Biology
  • Endocrinology

Background:

  • Type-1 diabetic pregnancy poses risks to fetal development.
  • Early pregnancy growth delay is common in diabetic pregnancies.
  • The impact of early growth delay on later fetal development requires further investigation.

Purpose of the Study:

  • To investigate the impact of early growth delay on birth weight.
  • To examine the effect of early growth delay on fetal behavioral state organization near term.
  • To explore the relationship between early growth delay and later functional development in type-1 diabetic pregnancies.

Main Methods:

  • Assessed early growth delay in fetuses of type-1 diabetic women.
  • Correlated early growth delay with birth weight centiles.
  • Analyzed fetal behavioral state parameters at 36 weeks gestation.

Main Results:

  • No significant relationship was found between early growth delay and birth weight.
  • A negative correlation (R = -0.59, P < 0.05) was observed between mean early growth delay and the absence of coincidence in fetal behavioral states at 36 weeks.
  • These findings suggest early developmental disruptions may precede later functional abnormalities.

Conclusions:

  • Early growth delay in type-1 diabetic pregnancies is not predictive of birth weight.
  • Early embryonic and fetal growth disorders may lead to abnormal functional development.
  • Later pregnancy growth (catch-up growth) appears to be the primary determinant of birth weight.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...